Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHuPH20 for Secondary Lymphedema
NCT01928030Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Dec 2013
- Primary completion
- Nov 2015
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hyaluronidase in secondary lymphedema, sponsored by Stanford University. Started Dec 2013; status: terminated.
02
Drugs
hyaluronidase
03
Conditions
secondary lymphedema
Beyond the preview
Go deeper on NCT01928030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928030.